Michio Nakamura

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Venues

BMJ open

Case reports in infectious diseases

Future oncology (London, England)

Pathology international

This page only lists publications with an associated author ORCID identifier.

Publications

Michio Nakamura, Ayako Watanabe, Aki Yoshizawa, Sari Iwasaki, Asako Nomura, Mariko Matsumura, Taichi Murai, Kazufumi Itaya, Yuta Koike, Takaaki Izumi, Ayana Endo, Shin Kato, Yuji Ono, Takahiro Ohshima, Nanase Okazaki, Shimpei Nakagawa, Yasushi Ishii, Yuichiro Fukasawa, Isao Yokota, Takahiro Tsuji, Shuji Nishikawa
The risk of weekend biopsy: Impact of specimen source and fixation status on HER2 assessment in the treatment of advanced gastric cancer (The HER_WEEKEND study). Pathology international (2023)
Yasuyuki Kawamoto, Satoshi Yuki, Kentaro Sawada, Michio Nakamura, Osamu Muto, Susumu Sogabe, Yoshiaki Shindo, Atsushi Ishiguro, Atsushi Sato, Yasushi Tsuji, Masayoshi Dazai, Hiroyuki Okuda, Takashi Meguro, Kazuaki Harada, Mari Sekiguchi, Kazufumi Okada, Yoichi M Ito, Yuh Sakata, Naoya Sakamoto, Yoshito Komatsu
Phase II Study of Ramucirumab Plus Irinotecan Combination Therapy as Second-Line Treatment in Patients with Advanced Gastric Cancer: HGCSG1603. The oncologist 27 (8) (2022)
Shintaro Nakano, Yasuyuki Kawamoto, Satoshi Yuki, Kazuaki Harada, Takuto Miyagishima, Susumu Sogabe, Masayoshi Dazai, Atsushi Sato, Atsushi Ishiguro, Michio Nakamura, Shinya Kajiura, Yasuo Takahashi, Miki Tateyama, Kazuteru Hatanaka, Yasushi Tsuji, Takahide Sasaki, Yoshiaki Shindo, Tomoe Kobayashi, Isao Yokota, Naoya Sakamoto, Yuh Sakata, Yoshito Komatsu
Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer. BMJ open 12 (5) (2022)
Risako Kohya, Taichi Murai, Yudai Taguchi, Kyohei Sawai, Masaya Takehara, Masahiro Nagahama, Kazufumi Itaya, Yuta Koike, Ayana Endo, Yuji Ono, Atsushi Nagasaka, Shuji Nishikawa, Michio Nakamura
An Autopsy Case of Rapidly Aggravated Clostridium perfringens Septicemia with Colorectal Cancer. Case reports in infectious diseases 2022 (2022)
Yukiya Narita, Hirokazu Shoji, Sadayuki Kawai, Takuro Mizukami, Michio Nakamura, Toshikazu Moriwaki, Takeharu Yamanaka, Yu Sunakawa, Hisato Kawakami, Tomohiro Nishina, Toshihiro Misumi, Kei Muro
REVIVE study: a prospective observational study in chemotherapy after nivolumab therapy for advanced gastric cancer. Future oncology (London, England) 17 (8) (2020)
Ayane Oba Aonuma, Michio Nakamura, Kentaro Sakamaki, Taichi Murai, Chika Matsuda, Kazufumi Itaya, Takayuki Sone, Masataka Yagisawa, Yuta Koike, Ayana Endo, Yoko Tsukuda, Yuji Ono, Atsushi Nagasaka, Shuji Nishikawa, Takeharu Yamanaka, Naoya Sakamoto
Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study). BMJ open 9 (8) (2019)

Michio Nakamura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michio Nakamura